Endovascular Function in Atrial Fibrillation (AF) Patients
NCT ID: NCT02062957
Last Updated: 2014-02-25
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
80 participants
OBSERVATIONAL
2014-02-28
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
2. endovascular function assessment with Peripheral Arterial Tonometry (PAT)
3. follow up the occurence of AF
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Complex Arrhythmia Registry
NCT07024927
A New Approach for Catheter Ablation of Atrial Fibrillation
NCT05989321
New-Onset Atrial Fibrillation Complicating Acute Myocardial Infarction in China
NCT05511649
Relationship Between Fibroblast Growth Factor 23 and Recurrence of Atrial Fibrillation After Catheter Ablation
NCT02958839
Quantification of Endothelial Thrombogenicity in Patients With Atrial Fibrillation
NCT02756429
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_CONTROL
PROSPECTIVE
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* electrocardiographic documentation of 1 persistent AF episode: (sustained for ≥7 days or cardioversion is performed more than 48h after AF onset): or
* electrocardiographic documentation of 1 longstanding persistent AF episode: (continuous AF of duration \>1 year).
Exclusion Criteria
* patients with coronary disease
* patients with peripheric artery disease
18 Years
80 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Beijing Chao Yang Hospital
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Guangzhen Zhong
associate professor
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Beijing Chaoyang Hospital
Beijing, , China
Countries
Review the countries where the study has at least one active or historical site.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Lin Han, Bachelor
Role: primary
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
NF81300148
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.